Iovance Biotherapeutics GAAP EPS of -$0.11 beats by $0.02, revenue of $99.31M beats by $11.48M

Iovance Biotherapeutics GAAP EPS of -$0.11 beats by $0.02, revenue of $99.31M beats by $11.48M